3,328
Views
55
CrossRef citations to date
0
Altmetric
ARTICLES

Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care

, MD & , MD, MPH

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Danielle Lenz, Tamarie Willis, Ayorkor Gaba, Michael Andre, William Eineman, Becca Newman, Sheryl Kubiak, Debra Pinals & David Smelson. (2023) Assessing the reentry needs of incarcerated individuals with co-occurring opioid use and mental health concerns. Journal of Offender Rehabilitation 62:8, pages 463-482.
Read now
Grant Victor, Ariel Roddy, Danielle Lenz, Tamarie Willis & Sheryl Kubiak. (2023) Applied machine learning analysis: Factors correlated with injection drug use and post-prison medication for opioid use disorder treatment engagement. Journal of Offender Rehabilitation 62:5, pages 297-314.
Read now
Britt Reuter Morthorst, Lars Mehlum, Sigurdur P. Pàlsson, Charlotte Mühlmann, Yngve Hammerlin, Trine Madsen, Merete Nordentoft & Annette Erlangsen. (2021) Suicide Rates in Nordic Prisons 2000–2016. Archives of Suicide Research 25:3, pages 704-714.
Read now
Grant A. Victor, Katie Bailey & Brad Ray. (2021) Buprenorphine Treatment Intake and Critical Encounters following a Nonfatal Opioid Overdose. Substance Use & Misuse 56:7, pages 988-996.
Read now
Noa Krawczyk, Ramin Mojtabai, Elizabeth A. Stuart, Michael I. Fingerhood, Deborah Agus, B. Casey Lyons, Jonathan P. Weiner & Brendan Saloner. (2021) Opioid agonist treatment is highly protective against overdose death among a U.S. statewide population of justice-involved adults. The American Journal of Drug and Alcohol Abuse 47:1, pages 117-126.
Read now
Nathan E. Kruis & Jaeyong Choi. (2020) Exploring Social Stigma toward Opioid and Heroin Users among Students Enrolled in Criminology, Nursing, and EMT/Paramedic Courses. Journal of Criminal Justice Education 31:3, pages 319-340.
Read now
Hilary L. Surratt, Michele Staton, Carl G. Leukefeld, Carrie B. Oser & J. Matthew Webster. (2018) Patterns of buprenorphine use and risk for re-arrest among highly vulnerable opioid-involved women released from jails in rural Appalachia. Journal of Addictive Diseases 37:1-2, pages 1-4.
Read now
Sarah E. Wakeman & Josiah D. Rich. (2018) Barriers to Medications for Addiction Treatment: How Stigma Kills. Substance Use & Misuse 53:2, pages 330-333.
Read now

Articles from other publishers (47)

Blythe E. Rhodes, Jessica Carda-Auten, Elena A. DiRosa & David L. Rosen. (2023) Provision of health care services related to substance use disorder in southern U.S. jails. Journal of Substance Use and Addiction Treatment, pages 209234.
Crossref
Brandon del Pozo, Jessica Reichert, Kaitlin Martins & Bruce Taylor. (2023) Police Use of Discretion in Encounters with People with Opioid Use Disorder: a Study of Illinois Police Officers. Journal of Police and Criminal Psychology.
Crossref
Nicole Milano, Jamey J. Lister & Grant Victor. (2023) Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid use disorder. The American Journal on Addictions 32:4, pages 352-359.
Crossref
Jessica L. AdlerWeiwei Chen. (2023) Jail Conditions And Mortality: Death Rates Associated With Turnover, Jail Size, And Population Characteristics. Health Affairs 42:6, pages 849-857.
Crossref
Daniel M. Hartung, Caitlin M. McCracken, Thuan Nguyen, Katherine Kempany & Elizabeth Needham Waddell. (2023) Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data. Journal of Substance Use and Addiction Treatment 147, pages 208971.
Crossref
Honora Englander, Jessica Gregg & Ximena A. Levander. (2022) Envisioning Minimally Disruptive Opioid Use Disorder Care. Journal of General Internal Medicine 38:3, pages 799-803.
Crossref
Cayley Russell, Frishta Nafeh, Michelle Pang, Shanna Farrell MacDonald, Dena Derkzen, Jürgen Rehm & Benedikt Fischer. (2022) Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study. BMC Public Health 22:1.
Crossref
Melissa N. Poulsen, Patrick B. Asdell, Wade Berrettini, Kortney McBryan & Alanna K. Rahm. (2022) Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study. SSM - Mental Health 2, pages 100151.
Crossref
Macpherson Uchenna Nnam, Gilbert Enyidah-Okey Ordu, Mary Juachi Eteng, Jonathan Akwagiobe Ukah, Christopher Chukwu Arua, Groupson-Paul Okechukwu & Cletus Onyema Obasi. (2021) “When I Take Drugs, I Don’t Care”: Insights into the Operational Dynamics of Male Violent Offenders in a Correctional Centre. International Journal of Offender Therapy and Comparative Criminology 66:13-14, pages 1454-1474.
Crossref
Ali Jalali, Philip J. Jeng, Daniel Polsky, Sabrina Poole, Yi-Chien Ku, George E. Woody & Sean M. Murphy. (2022) Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release. Journal of Substance Abuse Treatment 141, pages 108835.
Crossref
Grant Victor, Guijin Lee, Brandon del Pozo, Sydney Silverstein, Catherine Zettner, Rahni Cason & Bradley Ray. (2022) Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders. Journal of Drug Issues 52:3, pages 389-405.
Crossref
Brad Ray, Grant Victor, Rahni Cason, Nicole Hamameh, Sheryl Kubiak, Catherine Zettner, Megan Dunnigan, Erin Comartin & Matthew Costello. (2022) Developing a cascade of care for opioid use disorder among individuals in jail. Journal of Substance Abuse Treatment 138, pages 108751.
Crossref
Megan Kurz, Laura M. Dale, Jeong Eun Min, Natt Hongdilokkul, Leigh Greiner, Maureen Olley, Katherine E. McLeod, Amanda Slaunwhite & Bohdan Nosyk. (2021) Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada. Addiction 117:5, pages 1353-1362.
Crossref
Janan P. WyattLeslie W. SuenWilliam H. CoeZoe M. AdamsMona GandhiHannah M. BatchelorStacy CastellanosNeena JoshiShannon SatterwhiteRafael Pérez-RodríguezEsther Rodríguez-GuerraCarmen E. Albizu-GarciaKelly R. KnightAyana Jordan. (2022) Federal and State Regulatory Changes to Methadone Take-Home Doses: Impact of Sociostructural Factors. American Journal of Public Health 112:S2, pages S143-S146.
Crossref
Leslie W. SuenWilliam H. CoeJanan P. WyattZoe M. AdamsMona GandhiHannah M. BatchelorStacy CastellanosNeena JoshiShannon SatterwhiteRafael Pérez-RodríguezEsther Rodríguez-GuerraCarmen E. Albizu-GarciaKelly R. KnightAyana Jordan. (2022) Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19. American Journal of Public Health 112:S2, pages S112-S116.
Crossref
Elizabeth A. Evans, Donna Wilson & Peter D. Friedmann. (2022) Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence 231, pages 109254.
Crossref
Samer El Hayek, Bernadette Mdawar & Elias Ghossoub. (2022) Substance Misuse and the Older Offender. Clinics in Geriatric Medicine 38:1, pages 159-167.
Crossref
Elizabeth Monk-Turner, Hongyun Fu & Xiushi Yang. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1805 1829 .
Elizabeth Monk-Turner, Hongyun Fu & Xiushi Yang. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 26 .
Radha Sadacharan & Josiah D. Rich. 2022. Public Health Behind Bars. Public Health Behind Bars 403 416 .
Megha Ramaswamy & Nicholas Freudenberg. 2022. Public Health Behind Bars. Public Health Behind Bars 219 238 .
Christy K. Scott, Michael L. Dennis, Christine E. Grella, Allison F. Mischel & John Carnevale. (2021) The impact of the opioid crisis on U.S. state prison systems. Health & Justice 9:1.
Crossref
Nathan E. Kruis, Katherine McLean & Payton Perry. (2021) Exploring first responders' perceptions of medication for addiction treatment: Does stigma influence attitudes?. Journal of Substance Abuse Treatment 131, pages 108485.
Crossref
Noor Taweh, Esther Schlossberg, Cynthia Frank, Ank Nijhawan, Irene Kuo, Kevin Knight & Sandra A. Springer. (2021) Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. International Journal of Drug Policy 96, pages 103283.
Crossref
Veronica M. White, Sebastian Alvarez Avendano, Laura A. Albert, Aleksandra E. Zgierska, Captain Joe Balles & Gabriel Zayas-Cabán. (2021) Impact of a community-policing initiative promoting substance use disorder treatment over criminal charges on arrest recidivism. Drug and Alcohol Dependence 227, pages 108915.
Crossref
Megann Mitchell. (2021) Medicolegal Considerations in the Management of Opioid Use Disorder With Buprenorphine in the Correctional Setting. Journal of Correctional Health Care 27:3, pages 210-214.
Crossref
Michael S. Gordon, Shannon Gwin Mitchell, Thomas R. Blue, Frank J. Vocci, Marc J. Fishman, Sean M. Murphy, Kathy Couvillion, Kelly Maher, Danielle Ryan, Kevin Wenzel, Martha L. Danner & Daniel K. Jarvis. (2021) A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of Substance Abuse Treatment 128, pages 108241.
Crossref
Benjamin A. HowellRosemarie A. MartinRebecca LebeauAshley Q. TruongEmily A. WangJosiah D. RichJennifer G. Clarke. (2021) Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System. Health Affairs 40:8, pages 1304-1311.
Crossref
Hortensia Amaro, Mariana Sanchez, Tara Bautista & Robynn Cox. (2021) Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism. Neuropharmacology 188, pages 108518.
Crossref
Alexandra Duncan, Noah Sanders, Maria Schiff & Tyler N.A. Winkelman. (2021) Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic. Journal of Substance Abuse Treatment 121, pages 108161.
Crossref
Nathan E Kruis, Jaeyong Choi & Richard H Donohue. (2020) Police officers, stigma, and the opioid epidemic. International Journal of Police Science & Management 22:4, pages 393-406.
Crossref
Susan Schenk, Hedwig Eisenbarth & Louise Dixon. (2020) Treating opioid use disorders in the criminal justice system with pharmacotherapy. Forensic Science International: Mind and Law 1, pages 100009.
Crossref
. (2020) Improving Healthcare Access Among the Newly Decarcerated. Journal of Science Policy & Governance 17:02.
Crossref
Martin Krsak, Brian T Montague, Paul Trowbridge, Steven C Johnson & Ingrid A Binswanger. (2020) Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. The Journal of Infectious Diseases 222:Supplement_5, pages S486-S493.
Crossref
Christine E. Grella, Erika Ostile, Christy K Scott, Michael Dennis & John Carnavale. (2020) A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System. International Journal of Drug Policy 81, pages 102768.
Crossref
Jennifer K. Bello, Catherine Hearing, Joanne Salas, Jeremiah Weinstock & Donald Linhorst. (2019) Trends in Substance Use by Gender Among Participants in a Jail‐Based Substance Use Disorder Treatment Program: 1998–2016. Journal of Forensic Sciences 65:1, pages 97-102.
Crossref
Gregory G. Grecco & R. Andrew Chambers. (2019) The Penrose Effect and its acceleration by the war on drugs: a crisis of untranslated neuroscience and untreated addiction and mental illness. Translational Psychiatry 9:1.
Crossref
Noa Krawczyk, Megan Buresh, Michael S. Gordon, Thomas R. Blue, Michael I. Fingerhood & Deborah Agus. (2019) Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap. Journal of Substance Abuse Treatment 103, pages 1-8.
Crossref
Francisco Job Neto, Raquel Barbosa Miranda, Ronaldo de Almeida Coelho, Cinthya Paiva Gonçalves, Eliana Zandonade & Angelica Espinosa Miranda. (2019) Health morbidity in Brazilian prisons: a time trends study from national databases. BMJ Open 9:5, pages e026853.
Crossref
Hélène Poliquin, Lise Dassieu, Michel Perreault & Karine Bertrand. (2019) Le traitement de la dépendance aux opioïdes vu par des personnes qui font activement usage de drogues par injection à Montréal. Psychotropes Vol. 24:3, pages 111-134.
Crossref
Angela Russolillo, Akm Moniruzzaman & Julian M. Somers. (2019) Association of Methadone Treatment With Substance-Related Hospital Admissions Among a Population in Canada With a History of Criminal Convictions. JAMA Network Open 2:3, pages e190595.
Crossref
Pamela Valera, Andrea Reid, Nicholas Acuna & Daniel Mackey. (2019) The smoking behaviors of incarcerated smokers. Health Psychology Open 6:1, pages 205510291881993.
Crossref
Nikki Bozinoff, Kora DeBeck, M-J Milloy, Ekaterina Nosova, Nadia Fairbairn, Evan Wood & Kanna Hayashi. (2018) Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada. Drug and Alcohol Dependence 193, pages 42-47.
Crossref
Tyler N.A. Winkelman, Virginia W. Chang & Ingrid A. Binswanger. (2018) Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use. JAMA Network Open 1:3, pages e180558.
Crossref
Kelly E. Moore, Lindsay Oberleitner, Kathryn M.Z. Smith, Kathleen Maurer & Sherry A. McKee. (2018) Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal. Journal of Addiction Medicine 12:2, pages 156-162.
Crossref
David Hui, Zoe M. Weinstein, Debbie M. Cheng, Emily Quinn, Hyunjoong Kim, Colleen Labelle & Jeffrey H. Samet. (2017) Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. Journal of Substance Abuse Treatment 79, pages 12-19.
Crossref
Sarah Larney & Michael Farrell. (2016) Commentary on Binswanger et al . (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisons . Addiction 111:3, pages 511-512.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.